Ovid Therapeutics Inc. · NASDAQ:OVID
Federated Hermes, Inc.'s stake in Ovid Therapeutics Inc. fell to 4.15% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 8, 2026
Federated Hermes, Inc.'s stake in Ovid Therapeutics Inc. fell to 4.15%, 7,737,166 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).
- Stake
- 4.15%
- Shares
- 7,737,166
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Federated Hermes, Inc. | 4.15% | 7,737,166 |
| Voting Shares Irrevocable Trust | 4.15% | 7,737,166 |
| Thomas R. Donahue | 4.15% | 7,737,166 |
| Ann C. Donahue | 4.15% | 7,737,166 |
| J. Christopher Donahue | 4.15% | 7,737,166 |
Source
Related
- Ovid Therapeutics Inc.
- Federated Hermes, Inc.
- Ovid Therapeutics Inc. shareholders
- Schedule 13G · Federated Hermes, Inc. · Jan 8, 2026
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026